Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival

Anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets in ovarian carcinoma. Conversely, the role of the three AMH type I receptors (AMHRIs), namely activin receptor-like kinase (ALK)2, ALK3 and ALK6, in ovarian cancer remains to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvin, Maëva, Garambois, Véronique, Choblet, Sylvie, Colombo, Pierre-Emmanuel, Chentouf, Myriam, Gros, Laurent, De Brauwere, David-Paul, Duonor-Cerutti, Martine, Dumas, Karen, Robert, Bruno, Jarlier, Marta, Martineau, Pierre, Navarro-Teulon, Isabelle, Pépin, David, Chardès, Thierry, Pèlegrin, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131086/
https://www.ncbi.nlm.nih.gov/pubmed/34013359
http://dx.doi.org/10.3892/ijo.2021.5223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131086/
https://www.ncbi.nlm.nih.gov/pubmed/34013359
http://dx.doi.org/10.3892/ijo.2021.5223

Ejemplares similares